CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 2,370 shares (grant or award)
- 4 Grant or award Director acquired 3,160 shares (grant or award)
- DEFA14A Proxy Proxy Materials
- 4 Planned sale Head of Development sold 3,806 shares at $126.25 ($480,508)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 424B2 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 424B2 Offering Prospectus
- 4 Shares withheld for taxes Head of Corporate Development gave up 454 shares (to pay taxes)
- 4 Open-market buy Director bought 1,235 shares at $122.72 ($151,559)
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
Page 6 of 137 · 2,721 filings